AI 'writers' - threat or opportunity?
AI 'writers' - threat or opportunity?
Fri, Mar 31, 2023 1:00 PM IST (+01:00)
Free
Actions Panel
Are Chinese biopharmas globalising? Threat or Opportunity?
Helen Chen explains a possible new era of biopharma globalisation
By Healthcare Dialogues
When and where
Date and time
Thu, 16 Feb 2023 13:00 - 13:50 CET
Location
About this event
With China rapidly emerging from the Zero-Covid Strategy, can we expect its biopharma companies to aggressively expand into global markets?
- Will it be a smooth or a rocky ride?
- How do regulators in Europe and the US view Chinese biopharmas?
- Which companies should we look out for?
- What will the impact be for the established Western players?
Come listen to this and other viewpoints from one of the industry's leading experts, with full Q&A to follow.
Helen Chen heads L.E.K.’s China life sciences and healthcare practice, with extensive case work and industry experience covering the full biopharmaceutical and medtech value chain. A winner of the prestigious Global Leaders in Consulting for 2019 award from Consulting Magazine, Helen has 30+ years of consulting and industry experience in the U.S. and Asia, and has resided in China since 2000.
Places are limited. First come, first served.
Thursday 16th February
1pm - 1:50pm CET (Switzerland Time)
8pm - 9:50pm (China/HK/SG Time)